Evidence map›Paper›PMID 41311875›Full record

ArticleAsian biomedicine : research, reviews and news2025

Mobile health and hypertension in the digital era: patient perspectives on mHealth adoption and self-management in Saudi Arabia aligned with the digital health objectives of vision 2030.

Sultan M Alshahrani

Abstract read
In one paragraph

Article in Asian biomedicine : research, reviews and news, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sultan M AlshahraniDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Alfaraa, Abha 62223, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypertension remains a prominent public health concern in Saudi Arabia, contributing to cardiovascular morbidity and mortality. With widespread smartphone use and the national push toward digital transformation under Saudi Vision 2030, mobile health (mHealth) applications are a promising option for increasing self-management among hypertension patients. Objective: This study aims to analyze the acceptance, preferences, and perceived barriers toward utilizing mHealth applications for hypertension self-management among patients in Saudi Arabia. Methods: A cross-sectional survey was conducted from January to March 2025 utilizing an online, self-administered questionnaire disseminated across the 5 administrative regions of Saudi Arabia. The study investigated demographics, clinical factors, technology utilization, preferred app features, attitudes, and readiness to adopt mHealth solutions. Descriptive statistics and Pearson correlation analysis were employed. Results: Among the 1098 respondents, 55.3% were female, and the mean age was 45.0 ± 11.8 years. A majority (95.2%) owned cellphones, although only 22.1% had used a health-related app, and 11.8% had used one for hypertension. Most participants reported great interest in app features like medication reminders (78.4%) and blood pressure tracking (71.9%). Willingness to utilize mHealth was high (85.6%), and substantially linked with education level ( Conclusion: The study reveals considerable support for mHealth integration into hypertension care in Saudi Arabia. Tailoring app design to user demands and aligning deployment with Vision 2030's digital health agenda can boost chronic illness management and patient empowerment nationally.

Indexed as

digital healthhealth reformationhypertensionmHealth

Identifiers

PMID41311875
PMCPMC12649393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.